CatalystWireBeta

Total Voting Rights

In brief · summary, not quotable

Oxford Biomedica PLC announced that, as of October 31, 2025, its issued share capital consists of 120,497,010 ordinary shares, each with a value of 50 pence. The company confirms that it holds no ordinary shares in treasury. Therefore, the total number of voting rights is 120,497,010. This figure can be used by shareholders to determine if they need to notify the company of their interest or changes to their interest, according to FCA's Disclosure Guidance and Transparency Rules.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes

Oxford, UK - 03 November 2025: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company's issued share capital as at the close of business on 31 October 2025 consisted of 120,497,010 ordinary shares of 50 pence each ("Ordinary Shares"). There are no Ordinary Shares held in treasury.

Accordingly, the total number of voting rights in OXB at the date of this notice is 120,497,010.

The above figure 120,497,010 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, OXB under the FCA's Disclosure Guidance and Transparency Rules.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note